Search results
Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps
Maryland Matters via Yahoo News· 6 days agoThe Prescription Drug Affordability Board is seeking feedback from patients, physicians and manufactures to provide context and first-hand experience about trying to afford medications for certain ...
7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdowns
InvestorPlace· 6 days agoThe first one highlights the company’s leadership in digital services and advertising. Meanwhile,...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing
InvestorPlace· 6 days agoInvestors rarely have a reason to ignore Dividend Aristocrat stocks. Fortunately, several of the...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 7 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 3 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports. Barclays‘s ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie traded as low as $158.56 and last ...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks· 3 days agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...